services-02 By Posted September 10, 2014 In services-022014-09-102014-09-10https://apyxmedical.com/wp-content/uploads/2018/12/apyx-logo-footer_orange-white_150w.pngApyx Medicalhttps://apyxmedical.com/wp-content/uploads/2018/12/apyx-logo-footer_orange-white_150w.png200px200px 0 Recent PostsAPYX MEDICAL CORPORATION RELEASES ENVIRONMENTAL, SOCIAL AND GOVERNANCE DATA IN NEW TEAR SHEETRENUVION CLEARED BY FDA FOR NECK LAXITY PROCEDURES OFFERING PATIENTS A MINIMALLY INVASIVE OPTION TO ELIMINATE SAGGING NECKAPYX MEDICAL CORPORATION RECEIVES FDA 510(K) CLEARANCE FOR THE USE OF RENUVION TO IMPROVE APPEARANCE OF LAX (LOOSE) SKINAPYX MEDICAL CORPORATION ANNOUNCES RESULTS OF THE U.S. IDE CLINICAL STUDY EVALUATING THE USE OF RENUVION TO IMPROVE THE APPEARANCE OF LAX SKIN IN THE NECK AND SUBMENTAL REGION
